 |
 |
Anybody believes the "spokesperson of GSK"? If the medicines are in original containers with dates, there is no reason to assume they have been mishandled any more than those shipped to pharmacies in the US. As far as language and dosage amount in millliters, the language is most likely to be English and as far as I know no Parksinson medication comes in liquid form. So it is very probably the usual defense of profits... What else? Annette Mary Ann Rhyne, a GSK spokesperson, said that Canadian labels on the treatments may appear in a different language or have dosage amounts -- such as milliliters rather than teaspoons -- that differ from U.S. versions of the medications. In addition, the treatments may not be shipped to the United States "under proper conditions" of temperature, humidity and radiation "that would affect the safety and efficacy of a medicine," she said. Linda J Herman wrote: > GlaxoSmithKline is producer of ReQuip: > > --------- Forwarded message ---------- > This story was sent to you by [log in to unmask] from kaisernetwork.org > Daily Reports. > http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=15469 > > PRESCRIPTION DRUGS > > GlaxoSmithKline Says It Will No Longer Sell Products To Canadian > Companies That Market GSK Drugs to the United States > > GlaxoSmithKline said in Jan. 1 letters to Canadian pharmacies and > wholesalers that market GSK treatments over the Internet to the United > States and other nations that GSK will no longer sell products to > companies that continue the practice after Jan. 21, the Wall Street > Journal reports. "In the interest of patient safety and the maintenance > of an adequate product supply in (Canada)," GSK is "strongly against the > Internet sale and export of its Canadian medications," one of the letters > said (Lueck/Baglole, Wall Street Journal, 1/13). Mary Ann Rhyne, a GSK > spokesperson, said that Canadian labels on the treatments may appear in a > different language or have dosage amounts -- such as milliliters rather > than teaspoons -- that differ from U.S. versions of the medications. In > addition, the treatments may not be shipped to the United States "under > proper conditions" of temperature, humidity and radiation "that would > affect the safety and efficacy of a medicine," she said. GSK sent the > letters to six wholesalers and a few dozen pharmacies, she said (Loyd, > Philadelphia Inquirer, 1/13). > > Manitoba Industry Minister MaryAnn Minychuck said that she would > investigate whether GSK's decision to end product sales to some Canadian > pharmacies and wholesalers violated the free-trade agreement between the > United States and Canada (Wall Street Journal, 1/13). Rep. Bernard > Sanders (I-Vt.) said that the decision "seriously jeopardizes the health > and well-being of thousands of Americans," adding that he plans to > introduce legislation to prevent the move, the AP/Long Island Newsday > reports (Agovino, AP/Long Island Newsday, 1/11). > > Full Newsday article at: > http://www.newsday.com/news/health/wire/sns-ap-glaxo-canada0111jan11,0,21 > 14529.story > > --------------------------- > Please come and visit our site for future daily reports, or sign up for > our Email-Alert mailing list to automatically receive future reports at > http://www.kaisernetwork.org/email > > Daily Health Policy report > http://www.kaisernetwork.org/healthpolicyreport > > Daily HIV/AIDS Report > http://www.kaisernetwork.org/HIVAIDSreport > > Daily Reproductive Health Report > http://www.kaisernetwork.org/reproductivehealthreport > > -- Kaisernetwork.org, is a free service of the Kaiser Family Foundation > [log in to unmask] > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn